Other Viruses Citation List: April 24 - May 7, 2015
Hepatitis B Virus
1. Design, Synthesis, Biological Evaluation and Molecular Docking Studies of Phenylpropanoid Derivatives as Potent anti-Hepatitis B Virus Agents. Liu, S., W. Wei, Y. Li, X. Liu, X. Cao, K. Lei, and M. Zhou. European Journal of Medicinal Chemistry, 2015. 95: p. 473-482. PMID[25847765].
[PubMed]. OV_0424-050715.
Hepatitis C Virus
2. Selective Inhibitors of Cyclin G Associated Kinase (GAK) as anti-Hepatitis C Agents. Kovackova, S., L. Chang, E. Bekerman, G. Neveu, R. Barouch-Bentov, A. Chaikuad, C. Heroven, M. Sala, S. De Jonghe, S. Knapp, S. Einav, and P. Herdewijn. Journal of Medicinal Chemistry, 2015. 58(8): p. 3393-3410. PMID[25822739].
[PubMed]. OV_0424-050715.
3. Aspartic acid Based Nucleoside Phosphoramidate Prodrugs as Potent Inhibitors of Hepatitis C Virus Replication. Maiti, M., M. Maiti, J. Rozenski, S. De Jonghe, and P. Herdewijn. Organic & Biomolecular Chemistry, 2015. 13(18): p. 5158-5174. PMID[25849139].
[PubMed]. OV_0424-050715.
4. Epoxide Based Inhibitors of the Hepatitis C Virus Non-structural 2 Autoprotease. Shaw, J., C.W. Fishwick, and M. Harris. Antiviral Research, 2015. 117: p. 20-26. PMID[25703928].
[PubMed]. OV_0424-050715.
5. Beta-D-2'-C-Methyl-2,6-diaminopurine ribonucleoside phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5'-Triphosphate Forms. Zhou, L., H.W. Zhang, S. Tao, L. Bassit, T. Whitaker, T.R. McBrayer, M. Ehteshami, S. Amiralaei, U. Pradere, J.H. Cho, F. Amblard, D. Bobeck, M. Detorio, S.J. Coats, and R.F. Schinazi. Journal of Medicinal Chemistry, 2015. 58(8): p. 3445-3458. PMID[25849312].
[PubMed]. OV_0424-050715.
Herpes Simplex Virus 1
6. Anti-herpes Activity of Vinegar-processed Daphne Genkwa Flos via Enhancement of Natural Killer Cell Activity. Uyangaa, E., J.Y. Choi, H.W. Ryu, S.R. Oh, and S.K. Eo. Immune Network, 2015. 15(2): p. 91-99. PMID[25922598].
[PubMed]. OV_0424-050715.
Citations from the ISI Web of Knowledge Listings for O.V.
7. Virocidal Activity of Egyptian Scorpion Venoms against Hepatitis C Virus. El-Bitar, A.M.H., M.M.H. Sarhan, C. Aoki, Y. Takahara, M. Komoto, L. Deng, M.A. Moustafa, and H. Hotta. Virology Journal, 2015. 12(47): 9pp. ISI[000351815900001].
[WOS]. OV_0424-050715.
8. Monoclonal Antibodies against Extracellular Domains of Claudin-1 Block Hepatitis C Virus Infection in a Mouse Model. Fukasawa, M., S. Nagase, Y. Shirasago, M. Iida, M. Yamashita, K. Endo, K. Yagi, T. Suzuki, T. Wakita, K. Hanada, H. Kuniyasu, and M. Kondoh. Journal of Virology, 2015. 89(9): p. 4866-4879. ISI[000352219600016].
[WOS]. OV_0424-050715.
9. Depsides: Lichen Metabolites Active against Hepatitis C Virus. Vu, T.H., A.C. Le Lamer, C. Lalli, J. Boustie, M. Samson, F.L. Devehat, and J. Le Seyec. Plos One, 2015. 10(3): p. e0120405. ISI[000352083900027].
[WOS]. OV_0424-050715.
10. Synthesis and Antiviral Activity of Anthracene Derivatives of Isoxazolino-carbocyclic nucleoside Analogues. Memeo, M.G., F. Lapolla, G. Maga, and P. Quadrelli. Tetrahedron Letters, 2015. 56(15): p. 1986-1990. ISI[000352678900014].
[WOS]. OV_0424-050715.